Work

Impact of a five-dimensional framework on R&D productivity at AstraZeneca

Year: 2018

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd.2017.244

Authors: Paul Morgan, Dean G. Brown, Simon Lennard, Mark J. Anderton, J. Carl Barrett, Ulf Eriksson, Mark Fidock, Bengt Hamrén, Anthony Johnson, Ruth E. March, James Matcham, Jerome Mettetal, David J. Nicholls, Stefan Platz, Steve Rees, Michael A. Snowden, Menelas N. Pangalos

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States), AstraZeneca (Sweden)

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Drug Discovery

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca

OpenAlex ID: W2783569768

FWCI: 4.069

Cites: 131

Cited by: 475

Related to: 10